2022
DOI: 10.1016/j.biosx.2022.100233
|View full text |Cite
|
Sign up to set email alerts
|

Rapid, label-free and low-cost diagnostic kit for COVID-19 based on liquid crystals and machine learning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…(b) LC-based method for the diagnosis of COVID-19 and influenza types A and B based on the reorientation of LCs triggered by the addition of the specimen. Reproduced/redrawn with permission from ref . Copyright 2022 Elsevier.…”
Section: Detection Of Pathogensmentioning
confidence: 99%
See 3 more Smart Citations
“…(b) LC-based method for the diagnosis of COVID-19 and influenza types A and B based on the reorientation of LCs triggered by the addition of the specimen. Reproduced/redrawn with permission from ref . Copyright 2022 Elsevier.…”
Section: Detection Of Pathogensmentioning
confidence: 99%
“…It was possible to detect the SARS-CoV-2 virus using an LC-based diagnostic kit that could discriminate between COVID-19 samples that are −ve and +ve with an accuracy of 96% and between COVID-19 and influenza types A and B with an accuracy of 93%. This kit can be used for the rapid on-spot point of diagnosis of COVID-19 at border crossings, airports, and other locations Figure b represents a schematic diagram for the sensing and processing of LC biosensors for SARS-CoV-2 detection.…”
Section: Detection Of Pathogensmentioning
confidence: 99%
See 2 more Smart Citations
“…Prompt and accurate diagnosis of influenza helps prevent broad viral transmission throughout the residents and subsequent epidemics and pandemics, as well as reduce the unwanted use of medications in health care, which leads to the creation of antibiotic-resistant bacteria. In particular, older people and those with comorbidities benefit significantly from early treatment, which may include hydration and antiviral medicines [3,4]. The COVID-19 pandemic, along with the rise of telemedicine, has highlighted the need for accurate diagnosis of influenza without increasing the risk of transmission via direct human contact [5].…”
Section: Introductionmentioning
confidence: 99%